组件临床和成本结果 信息的补充价值:结核病诊断临床试验的案例研究
Pamela Pei1, Livia Qoshe2, Grady Florance2
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, USA. ppei@mgh.harvard.edu.
PharmacoEconomics
|March 6, 2026
概括
分解信息价值 (VOI) 分析揭示了成本节约和临床结果之间的权衡. 报告这些组成部分有助于利益相关者有效地优先考虑研究投资,即使总体净货币收益是积极的.
科学领域:
- 卫生经济学 卫生经济学
- 决策分析 决策分析
- 公共卫生 公共卫生
背景情况:
- 传统的信息价值 (VOI) 分析将临床和成本结果汇总成一个单一的指标.
- 这种聚合可以掩盖不同类型的结果之间的重要权衡.
- 利益相关者需要更清楚地了解推动研究价值的因素,以便做出明智的决定.
研究的目的:
- 通过估计和报告VOI分析的分类组件来突出信息性权衡.
- 让利益相关者能够确定什么驱动额外研究的价值.
主要方法:
- 一个微模拟模型被用来预测一个假设的试验对结核病查策略在南非住院的艾滋病毒患者的价值.
- 在评估VOI时,使用了汇总的净货币收益 (NMB) 和分类结果 (检测到的结核病例,死亡,寿命年数,医疗保健费用).
- 进行了概率敏感性分析,考虑了两个支付意愿门:3000美元/年薪和780美元/年薪.
主要成果:
- 在3000美元/YLS,最佳策略产生了有利的NMB (6543万美元),改善了临床结果,但成本更高 (+3740万美元).
- 在$780/YLS,最佳策略显示了积极的NMB ($250万) 和较低的成本 (-1100万美元),但更糟糕的临床结果 (较少的结核病病例,更多的死亡).
结论:
- 传统的VOI分析可能会显示出正的NMB,由于成本节省,尽管临床结果不利.
- VOI研究应该与聚合NMB一起报告分类结果,以更好地告知研究重点和决策.
相关概念视频
Pulmonary Tuberculosis IV
592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
Pulmonary Tuberculosis V
719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K


